Colorectal cancer resource library

    Showing 261–280 of 316 results

    Two women playing hand drums for community building at the AllyCamp volunteer training event.
    Blog

    Volunteer spotlight: Nancy Pope

    Get to know Colorectal Cancer Alliance volunteer Nancy Pope and consider being a service to the community yourself.

    bluehq video image
    Blog

    BlueHQ: Frequently Asked Questions

    BlueHQ is the Colorectal Cancer Alliance’s new patient and caregiver support hub. BlueHQ makes it easy to find personalized support, without endless online searching.

    “Colonoscopy” Trends with Twitter Reactions to Study
    Blog

    “Colonoscopy” trends with Twitter reactions to study

    A study out of Oslo, Norway, published in the New England Journal of Medicine questioned the effectiveness of colonoscopy in preventing colorectal cancer, the second deadliest cancer in the United States. The study triggered a swell of media reports casting doubt on the procedure.

    Blog

    Cancer Moonshot funding up for debate

    When it comes to the Federal Budget, the saying in Washington is the President proposes and Congress disposes. There is some truth to this.

    a photo that says "2024" with pictures of allies in the background
    Blog

    Five moments that mattered in 2024

    This year was the Alliance’s 25th year of impact, and we’re looking back on some of the milestones that made 2024 a year to remember.

    Blog

    Derek Dienner: A survivor behind the camera

    Earlier this year, six allies traveled to the media capital of the world to share their stories on camera. They were the first allies featured as part of the Colorectal Cancer Alliance’s Living Legacy Program.

    Official portraits of Donald Trump and Kamala Harris
    Blog

    Healthcare and the 2024 election

    We strongly encourage voters to contact the candidates in both parties and request information on their plans to improve access to healthcare and lower costs.

    Blog

    FDA approves new treatment for metastatic CRC with BRAF mutation

    The U.S. Food and Drug Administration has approved encorafenib (marketed as BRAFTOVI) in combination with cetuximab (marketed as ERBITUX) as a second-line therapy for the treatment of adult patients with metastatic colorectal cancer with a BRAFV600E mutation.

    Is There a Lynch Syndrome Vaccine on the Way?
    Blog

    Is a Lynch syndrome vaccine on the way?

    Developing a Lynch Syndrome vaccine could change the narrative for patients, reducing screenings and – more importantly – lowering risks for Lynch Syndrome-related cancers.

    support group three people

    Get connected with your allies

    There are many ways to find your community through the Alliance. Try one of our online communities.

    Learn More